Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desensitization Mechanisms in SLIT for Grass or Ragweed Allergy
NCT02676765Phase 3Terminated
- Sponsor
- Virginia Commonwealth University
- Start
- Jun 2016
- Primary completion
- Jan 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of SQ SLIT-tablet in allergic rhinitis (AR), sponsored by Virginia Commonwealth University. Started Jun 2016; status: terminated.
02
Drugs
SQ SLIT-tablet
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02676765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02676765.